Coloplast A/S Annual General Meeting Details
Coloplast A/S is gearing up for its upcoming Annual General Meeting, a significant event marked on the calendars of investors and stakeholders alike. This meeting is set to take place on a Thursday at the company's premises located in Humlebæk, Denmark, in the prestigious Aage Louis-Hansen Auditorium. Although the exact date is not specified, anticipation builds around what this event will bring.
Key Information for Investors
Investors and analysts can look forward to obtaining critical insights during the meeting. Coloplast A/S is committed to maintaining transparency and open communication, as emphasized by their Executive Vice President and CFO, Anders Lonning-Skovgaard. The Vice President of Investor Relations, Aleksandra Dimovska, will also be available for inquiries and discussions.
Contact Information for Investors
Should you need to reach out for further clarification or additional details, the contact information is as follows:
Anders Lonning-Skovgaard, Executive Vice President, CFO. Phone: +45 4911 1111.
Aleksandra Dimovska, Vice President, Investor Relations Phone: +45 4911 1800 / +45 4911 2458. Email: dkadim@coloplast.com.
Press and Media Inquiries
For those in the media, Peter Mønster, the Senior Media Relations Manager, is available for inquiries. Media professionals can connect with him at +45 4911 2623 or via email at dkpete@coloplast.com. This openness fosters a robust relationship between Coloplast and the public, enhancing the company's reputation.
Company Address and Registration
If you're looking to contact Coloplast A/S directly, their main address is:
Coloplast A/S
Holtedam 1
DK-3050 Humlebaek
Denmark
Company registration number: CVR no. 69749917.
Understanding Coloplast's Commitment
Coloplast is not just a healthcare company; it's a mission driven by passion and empathy. Founded upon the inspiration of a nurse wanting to help her sister, the company has established itself as a leader in addressing intimate healthcare needs. Their diverse range of products and services aims to empower millions worldwide, enabling them to lead more independent lives.
Innovative Product Lines
Coloplast’s business encompasses several key areas, including Ostomy Care, Continence Care, Advanced Wound and Skin Care, Interventional Urology, and Voice and Respiratory Care. The breadth of their offerings reflects a commitment to innovation, ensuring that patients receive the best possible care and support.
The Importance of the Logo
The Coloplast logo is not merely a symbol; it represents the company's legacy and commitment to their mission. As a registered trademark, it stands for quality and trust in the healthcare market.
Future Directions for Coloplast A/S
Looking ahead, shareholders can anticipate more information surrounding strategic directions and business developments during the Annual General Meeting. As the company continues to grow and adapt to the healthcare landscape, updates at the meeting may offer insights into future innovations that could potentially enhance shareholder value.
Frequently Asked Questions
What is the purpose of the Annual General Meeting for Coloplast?
The Annual General Meeting serves to inform shareholders of company developments, financial performance, and future strategies while allowing them to participate in decision-making.
Where will the meeting take place?
The meeting will be held at Coloplast A/S's headquarters in Humlebæk, Denmark.
How can investors contact Coloplast for more information?
Investors can contact the Investor Relations team, specifically Aleksandra Dimovska at +45 4911 1800 or email dkadim@coloplast.com.
Who should media inquiries be directed to?
Media inquiries should be directed to Peter Mønster, Senior Media Relations Manager, at +45 4911 2623 or email dkpete@coloplast.com.
What are the key areas Coloplast operates in?
Coloplast operates in Ostomy Care, Continence Care, Advanced Wound and Skin Care, Interventional Urology, and Voice and Respiratory Care.
